Document is current
Any future updates will be listed below
-
Authors
O’Connor, Meaghan https://orcid.org/0000-0001-6576-2952
Broderick, Lynne https://orcid.org/0000-0001-8783-9877
Waldman, Laura Tesler https://orcid.org/0000-0001-9968-7057
Costa, Elizabeth https://orcid.org/0009-0000-1567-3281
Carty, Michelle https://orcid.org/0000-0003-2450-7693
Nunna, Sasikiran https://orcid.org/0000-0002-8006-7306
Oberdhan, Dorothee https://orcid.org/0000-0003-1034-9049
-
Funding
Funding for this research was provided by:
Otsuka Pharmaceutical Development and Commercialization, Inc.
- License Information
-
More Information
Article History
Received: 15 November 2025
Accepted: 4 February 2026
First Online: 10 March 2026
Declarations
:
: Dorothee Oberdhan and Sasikiran Nunna are employees of Otsuka Pharmaceutical Development and Commercialization, Inc. (Otsuka). Meaghan O’Connor, Lynne Broderick, Laura Tesler Waldman, Elizabeth Costa, and Michelle Carty are/were employees of IQVIA, Inc. which received funding from Otsuka to complete the research described in this manuscript.
: This study was reviewed and approved by WCG IRB (IRB study number 1334669). All participants received a study information sheet with details about the study prior to being interviewed. Participants also provided verbal consent at the start of each interview.
